Healthcare provider profile · identity verified

Alan C Smith, MD

Family Practice · ORCHARD PARK, NY · NPI 1477509602

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Eliquis	Apixaban	464	42
Atorvastatin Calcium	Atorvastatin Calcium	369	54
Levothyroxine Sodium	Levothyroxine Sodium	332	47
Metoprolol Succinate	Metoprolol Succinate	312	52
Amlodipine Besylate	Amlodipine Besylate	288	43
Sertraline Hcl	Sertraline Hcl	279	40
Furosemide	Furosemide	250	42
Gabapentin	Gabapentin	234	30
Lisinopril	Lisinopril	147	22
Potassium Chloride	Potassium Chloride	145	24
Memantine Hcl	Memantine Hcl	136	19
Tamsulosin Hcl	Tamsulosin Hcl	136	23
Carbidopa-Levodopa	Carbidopa/Levodopa	134	17
Metoprolol Tartrate	Metoprolol Tartrate	132	20
Donepezil Hcl	Donepezil Hcl	131	20
Famotidine	Famotidine	124	16
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	117	31
Omeprazole	Omeprazole	117	18
Clopidogrel	Clopidogrel Bisulfate	113	18
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	112	23
Jardiance	Empagliflozin	111	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	108	14
Pantoprazole Sodium	Pantoprazole Sodium	106	19
Latanoprost	Latanoprost	103	15
Myrbetriq	Mirabegron	90	suppressed
Ondansetron Hcl	Ondansetron Hcl	89	26
Rosuvastatin Calcium	Rosuvastatin Calcium	83	15
Mirtazapine	Mirtazapine	81	13
Trazodone Hcl	Trazodone Hcl	80	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	76	suppressed
Metformin Hcl	Metformin Hcl	72	suppressed
Buspirone Hcl	Buspirone Hcl	70	11
Duloxetine Hcl	Duloxetine Hcl	66	suppressed
Pravastatin Sodium	Pravastatin Sodium	64	suppressed
Tramadol Hcl	Tramadol Hcl	64	17
Bumetanide	Bumetanide	63	11
Chlorhexidine Gluconate	Chlorhexidine Gluconate	63	12
Levetiracetam	Levetiracetam	61	suppressed
Methotrexate	Methotrexate Sodium	60	suppressed
Baclofen	Baclofen	58	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	58	suppressed
Prednisone	Prednisone	58	13
Lorazepam	Lorazepam	55	15
Allopurinol	Allopurinol	54	suppressed
Finasteride	Finasteride	54	suppressed
Gemtesa	Vibegron	54	suppressed
Divalproex Sodium	Divalproex Sodium	53	suppressed
Fluticasone Propionate	Fluticasone Propionate	50	11
Aripiprazole	Aripiprazole	49	suppressed
Losartan Potassium	Losartan Potassium	49	suppressed
Carvedilol	Carvedilol	47	suppressed
Valsartan	Valsartan	47	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	44	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	44	suppressed
Simvastatin	Simvastatin	43	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	40	suppressed
Warfarin Sodium	Warfarin Sodium	39	suppressed
Xarelto	Rivaroxaban	39	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	37	11
Bupropion Xl	Bupropion Hcl	37	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	35	suppressed
Januvia	Sitagliptin Phosphate	35	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	34	suppressed
Atenolol	Atenolol	33	suppressed
Hydralazine Hcl	Hydralazine Hcl	33	suppressed
Irbesartan	Irbesartan	33	suppressed
Clonidine Hcl	Clonidine Hcl	32	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	32	32
Doxycycline Hyclate	Doxycycline Hyclate	31	13
Glipizide	Glipizide	29	suppressed
Cyclosporine	Cyclosporine	28	suppressed
Montelukast Sodium	Montelukast Sodium	27	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Oxycodone Hcl	Oxycodone Hcl	26	suppressed
Ropinirole Hcl	Ropinirole Hcl	26	suppressed
Rexulti	Brexpiprazole	25	suppressed
Alprazolam	Alprazolam	24	suppressed
Farxiga	Dapagliflozin Propanediol	24	suppressed
Lamotrigine	Lamotrigine	23	suppressed
Vraylar	Cariprazine Hcl	23	suppressed
Calcitriol	Calcitriol	22	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Metformin Hcl Er	Metformin Hcl	21	suppressed
Nuplazid	Pimavanserin Tartrate	21	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	21	suppressed
Spironolactone	Spironolactone	21	suppressed
Digoxin	Digoxin	20	suppressed
Memantine Hcl Er	Memantine Hcl	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	19	suppressed
Trimethoprim	Trimethoprim	19	suppressed
Tizanidine Hcl	Tizanidine Hcl	18	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Galantamine Er	Galantamine Hbr	17	suppressed
Methadone Hcl	Methadone Hcl	17	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Risperidone	Risperidone	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	14
Travoprost	Travoprost	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	13
Ozempic	Semaglutide	16	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	15	13
Cephalexin	Cephalexin	15	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	15	suppressed
Humalog	Insulin Lispro	15	suppressed
Meloxicam	Meloxicam	15	suppressed
Methocarbamol	Methocarbamol	15	suppressed
Midodrine Hcl	Midodrine Hcl	15	suppressed
Nitroglycerin	Nitroglycerin	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	suppressed
Trulicity	Dulaglutide	15	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	15	suppressed
Azithromycin	Azithromycin	14	suppressed
Brilinta	Ticagrelor	14	suppressed
Terazosin Hcl	Terazosin Hcl	14	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	13	12
Ezetimibe	Ezetimibe	13	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Lactulose	Lactulose	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Mesalamine	Mesalamine	13	suppressed
Timolol Maleate	Timolol Maleate	13	suppressed
Budesonide	Budesonide	12	suppressed
Citalopram Hbr	Citalopram Hydrobromide	12	suppressed
Dexlansoprazole Dr	Dexlansoprazole	12	suppressed
Dorzolamide-Timolol	Dorzolamide/Timolol/Pf	12	suppressed
Entacapone	Entacapone	12	suppressed
Galantamine Hbr	Galantamine Hbr	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Morphine Sulfate	Morphine Sulfate	12	11
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Ranolazine Er	Ranolazine	12	suppressed
Trospium Chloride Er	Trospium Chloride	12	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	12	suppressed
Amantadine	Amantadine Hcl	11	suppressed
Anastrozole	Anastrozole	11	suppressed
Haloperidol Lactate	Haloperidol Lactate	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	11	suppressed
Lumigan	Bimatoprost	11	suppressed
Methimazole	Methimazole	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Riluzole	Riluzole	11	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	11	suppressed
Torsemide	Torsemide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error